About COPD Uncovered
COPD Uncovered represents the combined efforts of a multi-disciplinary committee of international experts, coming together to bring forward some of the most burning issues in COPD today. Their aim is to highlight the impact of COPD in an understudied and ignored patient segment between the ages of 40 and 65.
The COPD Uncovered initiative is a compendium of research and analysis undertaken by experts in respiratory health. This initiative is sponsored by Novartis Pharma AG and is administered by a Secretariat from Chandler Chicco Companies (CCC). The studies underlying the COPD Uncovered Report were commissioned by Novartis Pharma AG.
Following the release of this report, the COPD Uncovered experts are conducting further quantitative research into the direct and indirect costs of the disease among this age group. In 2010, they expect to release the results of the study that will look at the specific impact of COPD on the daily lives of more than 2,000 COPD patients aged 45-67 from the U.S., the UK, Germany, Brazil, China and Turkey.
About the Authors
The COPD Uncovered Report, issued on World COPD Day 2009, is authored by the following individuals, supported by Novartis with editorial assistance from medical education specialists from CCC:
- Monica Fletcher, Chief Executive, Education for Health and National Respiratory Training Center, principle lead for COPD Uncovered - Dr Marianella Salapatas, President, European Federation of Allergy and Airways Diseases Patients' Associations - Professor Thys van der Molen, Department of General Practice, University of Groningen - John Walsh, President and CEO, COPD Foundation To download a copy of the COPD Uncovered report, visit: '/>"/>
|SOURCE Education for Health|
Copyright©2009 PR Newswire.
All rights reserved